VEGF and Pleiotrophin Modulate the Immune Profile of Breast Cancer
Angiogenesis, the sprouting of the existing vascular network to form new vessels, is required for the growth of solid tumors. For this reason, the primary stimulant of angiogenesis, vascular endothelial growth factor-A (VEGF), is an attractive target for tumor therapy. In fact, there are currently n...
Main Authors: | Kristi D. Lynn, Christina L. Roland, Rolf A. Brekken |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/2/2/970/ |
Similar Items
-
VEGF, VEGF165b and EG-VEGF expression is specifically related with hormone profile in pituitary adenomas
by: Ana Silvia Corlan, et al.
Published: (2019-03-01) -
Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer
by: Minna Sopo, et al.
Published: (2019-06-01) -
Μελέτη του ρόλου του αυξητικού παράγοντα πλειοτροπίνη και του υποδοχέα της RPTPβ/ζ στην επαγόμενη από τον αγγειογενετικό παράγοντα VEGF κυτταρική μετανάστευση
by: Θεοδωροπούλου, Χριστίνα
Published: (2011) -
The Anti-VEGF(R) Drug Discovery Legacy: Improving Attrition Rates by Breaking the Vicious Cycle of Angiogenesis in Cancer
by: Domenico Ribatti, et al.
Published: (2021-07-01) -
Influence of VEGF deprivation upon vascular formation by endothelium in the presence of macrophages
by: A. R. Kozyreva, et al.
Published: (2020-04-01)